Scarica l'app Stockscreener
52.92
0.79%
-0.42
Dopo l'orario di chiusura:
53.04
0.12
+0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$53.34
Aprire:
$53.19
Volume 24 ore:
2.40M
Relative Volume:
1.05
Capitalizzazione di mercato:
$8.23B
Reddito:
$1.17B
Utile/perdita netta:
$150.71M
Rapporto P/E:
56.30
EPS:
0.94
Flusso di cassa netto:
$245.03M
1 W Prestazione:
-2.60%
1M Prestazione:
-3.57%
6M Prestazione:
-11.98%
1 anno Prestazione:
-25.59%
Intervallo 1D:
$51.62
$53.19
Intervallo di 1 settimana:
$51.62
$55.25
Portata 52W:
$46.01
$80.95
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
(612) 379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Confronta TECH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
52.92 | 8.31B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-07-09 | Iniziato | TD Cowen | Buy |
| 2025-05-30 | Iniziato | Wells Fargo | Overweight |
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-08-28 | Iniziato | William Blair | Outperform |
| 2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
| 2021-01-25 | Reiterato | The Benchmark Company | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Downgrade | Stifel | Buy → Hold |
| 2020-05-14 | Iniziato | The Benchmark Company | Buy |
| 2020-01-08 | Ripresa | Stephens | Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-17 | Iniziato | Goldman | Neutral |
| 2018-06-15 | Iniziato | Argus | Buy |
| 2017-07-13 | Iniziato | Wells Fargo | Market Perform |
| 2017-02-09 | Iniziato | Citigroup | Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
Can Bio Techne Corporation benefit from deglobalizationWeekly Profit Summary & Stock Portfolio Risk Control - khodrobank.com
Bio-Techne at Wells Fargo: Navigating Growth Amid Tariff Concerns - Investing.com
Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry PointBio-Techne (NASDAQ:TECH) - Benzinga
Bio-Techne Corp. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Market reaction to Bio Techne Corporation’s recent newsTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - Newser
Quantitative breakdown of Bio Techne Corporation recent move2025 Earnings Surprises & Safe Swing Trade Setup Alerts - Newser
Candlestick signals on Bio Techne Corporation stock todayMarket Performance Recap & Capital Efficiency Focused Ideas - Newser
Using portfolio simulators with Bio Techne Corporation includedWeekly Risk Report & Capital Efficiency Focused Strategies - Newser
Is Bio Techne Corporation a candidate for recovery playInsider Selling & Precise Buy Zone Tips - Newser
Is Bio Techne Corporation still worth holding after the dip2025 Trade Ideas & Weekly Hot Stock Watchlists - Newser
Is Bio Techne Corporation stock a good dividend stock2025 Winners & Losers & Daily Stock Trend Watchlist - khodrobank.com
Why Bio-Techne (TECH) Shares Are Sliding Today - Yahoo Finance
Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MSN
How high can Bio Techne Corporation stock goMarket Growth Summary & Scalable Portfolio Growth Methods - Newser
What earnings revisions data tells us about Bio Techne CorporationQuarterly Market Summary & Community Consensus Trade Alerts - Newser
Bio Techne Corporation stock outlook for YEARWeekly Loss Report & Weekly High Return Forecasts - Newser
Applying chart zones and confluence areas to Bio Techne CorporationJuly 2025 Analyst Calls & High Accuracy Trade Alerts - Newser
How to interpret RSI for Bio Techne Corporation stock2025 EndofYear Setup & Verified Trade Idea Suggestions - Newser
Can Bio Techne Corporation outperform in the next rallyJuly 2025 Recap & Weekly Momentum Picks - khodrobank.com
Is it time to cut losses on Bio Techne CorporationJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - Newser
Published on: 2025-09-01 12:30:20 - Newser
Using Ichimoku Cloud for Bio Techne Corporation technicalsJuly 2025 Selloffs & Precise Swing Trade Alerts - Newser
What machine learning models say about Bio Techne CorporationBear Alert & Community Consensus Picks - Newser
Chart based exit strategy for Bio Techne CorporationPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Automated trading signals detected on Bio Techne CorporationMarket Activity Report & Consistent Profit Trading Strategies - Newser
Published on: 2025-08-30 21:11:50 - Newser
Applying big data sentiment scoring on Bio Techne Corporation2025 Volume Leaders & Weekly Momentum Picks - Newser
Using economic indicators to assess Bio Techne Corporation potentialQuarterly Profit Summary & Weekly High Return Forecasts - Newser
Real time alert setup for Bio Techne Corporation performance2025 Key Lessons & Breakout Confirmation Alerts - Newser
Fibonacci Retracement Aligns with Support in Bio Techne Corporation getLinesFromResByArray error: size == 0 - 클래시안
Tools to monitor Bio Techne Corporation recovery probabilityJuly 2025 Outlook & Weekly Return Optimization Alerts - Newser
Published on: 2025-08-28 20:41:13 - Newser
Using Python tools to backtest Bio Techne Corporation strategiesEntry Point & Long-Term Safe Return Strategies - Newser
Bio-Techne Corp to Present at Several Upcoming Investor Conferences - AInvest
BIO-TECHNE Corp Directors Execute Share Sales - TradingView
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bio Techne Corp Azioni (TECH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Nusse Roeland | Director |
Aug 25 '25 |
Sale |
56.36 |
17,040 |
960,388 |
44,559 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Option Exercise |
21.84 |
17,040 |
372,154 |
61,903 |
| BAUMGARTNER ROBERT V | Director |
Aug 25 '25 |
Sale |
56.21 |
17,040 |
957,818 |
44,863 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):